Indications, labeling, and outcomes assessment for drugs aimed at improving functional status in older persons: a conversation between aging researchers and FDA regulators.
Boston University School of Medicine, Boston, MA, USA.
Bhasin
Shalender
S
Espeland
Mark A
MA
Evans
William J
WJ
Ferrucci
Luigi
L
Fried
Linda P
LP
Gill
Thomas M
TM
Pahor
Marco
M
Studenski
Stephanie
S
Guralnik
Jack
J
Nayfield
Susan
S
Romashkin
Sergei
S
Perlstein
Robert
R
Burke
Laurie
L
Parks
Mary
M
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000187:drug effects* / Q000502:physiology; D003072:Cognition Disorders / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D016330:Frail Elderly; D015577:Geriatric Assessment; D006801:Humans; D033183:Interdisciplinary Communication; D008297:Male; D017063:Outcome Assessment, Health Care; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D010809:Physical Fitness / Q000502:physiology; D017410:Practice Guidelines as Topic; D012106:Research / Q000592:standards; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations